Multi-antigen therapeutic HIV DNA vaccine - Profectus BioSciences

Drug Profile

Multi-antigen therapeutic HIV DNA vaccine - Profectus BioSciences

Alternative Names: HIV MAG pDNA vaccine; PBX Vax™ prime/boost HIV; ProfectusVax DNA Plasmid HIV-1 nef/tat/vif, env; ProfectusVaxVSV IN HIV envC

Latest Information Update: 27 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Profectus Biosciences
  • Developer National Institute of Allergy and Infectious Diseases; Profectus Biosciences
  • Class AIDS vaccines; DNA vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I HIV-1 infections

Most Recent Events

  • 27 Jul 2016 The programme is still in active development for HIV-1 infections following programme review
  • 26 Jul 2016 Phase-I clinical trials in HIV-1 infections (Prevention, In volunteers) in Kenya (IM)
  • 26 Jul 2016 Phase-I clinical trials in HIV-1 infections (Prevention, In volunteers) in Rwanda (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top